Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
about
A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.Bacterial antibiotic resistance before and after clinical application in the United States.Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.Cefmenoxime penetration into gallbladder bile and tissue.In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalisEfficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.Influence of inoculum size on comparative susceptibilities of penicillinase-positive and -negative Neisseria gonorrhoeae to 31 antimicrobial agents.The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years.Antimicrobial activity of cefmenoxime compared with those of other cephalosporins.Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.Cerebrospinal fluid penetration of cefmenoxime in children with bacterial meningitis.
P2860
Q34707883-722EA898-20B8-4B72-8A72-74A787A653B6Q35119490-795148A9-129D-442A-A3F8-15A1729ADCCDQ35641057-91DA2430-27BE-4371-90B5-D3E7E3380CA3Q35745724-7315EB65-EC8E-4244-8591-5BA82906E0F3Q35760623-6DB84BAB-80C5-4FEB-8CAE-23DB8E51A0C5Q37269692-69F71741-3FEA-445F-882A-E8045F2BDD92Q39850274-9A8C3DF9-5F16-4C6A-9F44-88A351A32FFDQ40283286-643F9F54-2EEE-4D1A-AC0D-788BE72A5977Q40584325-ADC6402B-EAAD-46B9-B290-44F2B6584C12Q41895847-4F8A4D3B-889D-4B33-9393-69C53DEBE7ABQ42253836-5EAF6A57-9B65-4D3D-AEBE-DFE17A2DF740Q44099291-1FC396FC-543B-4378-8337-7D037C77DA2C
P2860
Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Cefmenoxime (SCE-1365), a new ...... ntative interpretive criteria.
@ast
Cefmenoxime (SCE-1365), a new ...... ntative interpretive criteria.
@en
type
label
Cefmenoxime (SCE-1365), a new ...... ntative interpretive criteria.
@ast
Cefmenoxime (SCE-1365), a new ...... ntative interpretive criteria.
@en
prefLabel
Cefmenoxime (SCE-1365), a new ...... ntative interpretive criteria.
@ast
Cefmenoxime (SCE-1365), a new ...... ntative interpretive criteria.
@en
P2093
P2860
P356
P1476
Cefmenoxime (SCE-1365), a new ...... ntative interpretive criteria.
@en
P2093
P2860
P304
P356
10.1128/AAC.20.6.747
P407
P577
1981-12-01T00:00:00Z